SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
DARE

Dare Bioscience, Inc. (NASDAQ:DARE)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$0.41-$0.04 (-9.87%)
 
Market cap
$8.01M
Insider Score
Health Score
Analyst consensus
Listed since
Apr 10, 2014

DARE analyst forecast

Best analysts covering DARE

  • HC Wainwright & Co.6%success rate · -44.8% avg return · 16 calls

Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.

DARE analyst ratings

FirmPrice targetAction
—HC Wainwright & Co.Buy——Reiterated2025-12-02

DARE earnings vs. estimates

QuarterEPS est.EPS actualRevenue est.Revenue actual
2026-03-26-$0.24-$0.02$752K$1.0M
2026-05-14-$0.33-$0.20$27K$152K
2026-08-13-$0.30-$0.20$2K$188K
2026-11-16-$0.13-$0.18$2.0M$48K
2027-03-25Upcoming-$0.20—$319K—
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.